Mandate

Vinge has advised Randviken Fastigheter AB (publ) in connection with its change of company object and re-listing on Nordic SME

Vinge advises Randviken Fastigheter AB (publ) (”Randviken”) in connection with its change of company object and re-listing on Nordic SME (Nordic Growth Market). The Company Description was made public on 31 August 2021. The change of the company object was due to an indirect acquisition of 35 properties amounting to a total value of SEK 2,778 million.

Randviken is a real estate company with the aim to acquire, manage and refine properties in different segments and geographical locations. In addition to Randviken’s primary focus on stable and long-term cash flows from rented premises, the company’s ambition is to actively engage with intelligent technology to achieve more sustainable and energy efficient properties.

Randviken is listed on Nordic SME (Nordic Growth Market).

Vinges team included David Andersson, Julia Hirschberg and Olivia Belding (Capital Markets and Public M&A), Niclas Winnberg, Kristoffer Larson, Frida Ställborn and Ulf Pyk (Real Estate), as well as Fabian Ekeblad, Paulina Malmberg and Elin Samara (Banking and Finance).

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025